Sunshine Biopharma Inc.
Ticker: 1402328
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 9.26+14.5% | 8.09-14.1% | 9.42+0.1% | 9.41+5.7% | 8.90+5.5% | 8.44-9.2% | 9.30+0.0% | 9.30 |
| Total Income | 9.26+14.5% | 8.09-14.1% | 9.42+0.1% | 9.41+5.7% | 8.90+5.5% | 8.44-9.2% | 9.30+0.0% | 9.30 |
| EXPENSES | ||||||||
| Expenditure | 10.88+14.8% | 9.48-9.7% | 10.50-8.4% | 11.46+12.4% | 10.20+6.9% | 9.54-9.7% | 10.57+0.0% | 10.57 |
| Tax | 0.00 | 0.00+100.0% | -0.14+33.3% | -0.21-425.0% | -0.04-118.2% | 0.22+164.7% | -0.34+0.0% | -0.34 |
| PROFIT | ||||||||
| PBT | -1.56-25.8% | -1.24-21.6% | -1.02+48.5% | -1.98-62.3% | -1.22-24.5% | -0.98-16.7% | -0.84+0.0% | -0.84 |
| Net Profit | -1.56-25.8% | -1.24-40.9% | -0.88+50.3% | -1.77-50.0% | -1.18+1.7% | -1.20-144.9% | -0.49+0.0% | -0.49 |
| KEY METRICS | ||||||||
| OPM % | -17.41%-0.16pp | -17.25%-5.72pp | -11.54%+10.29pp | -21.83%-7.28pp | -14.56%-1.44pp | -13.12%+0.52pp | -13.63% | -13.63% |
| NPM % | -16.88%-1.51pp | -15.38%-5.99pp | -9.38%+9.43pp | -18.82%-5.56pp | -13.25%+0.95pp | -14.20%-8.89pp | -5.31% | -5.31% |
| EPS | -1.15-360.0% | -0.25-31.6% | -0.19+51.3% | -0.39+11.4% | -0.44+53.2% | -0.94+90.5% | -9.94+0.0% | -9.94 |
Corporate Events
Board MeetingSBFM
202615Sep
Board Meeting
Shareholder approval for a reverse stock split of up to 1-fo…
SEC Filing ↗ Board MeetingSBFM
202628May
Board Meeting
Shareholder approval for the issuance of common stock at a d…
SEC Filing ↗